ARWR: Germany patients get access to REDEMPLO (plozasiran)
ARWR says people living with familial chylomicronaemia syndrome (FCS) in Germany have access to REDEMPLO (plozasiran) as a new treatment option to reduce triglycerides.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.